Is current treatment increasing asthma mortality and morbidity?
作者信息
Mitchell E A
机构信息
Department of Paediatrics, School of Medicine, University of Auckland, New Zealand.
出版信息
Thorax. 1989 Feb;44(2):81-4. doi: 10.1136/thx.44.2.81.
Abstract
摘要
相似文献
1
Is current treatment increasing asthma mortality and morbidity?当前的治疗方法是否正在增加哮喘的死亡率和发病率？
Thorax. 1989 Feb;44(2):81-4. doi: 10.1136/thx.44.2.81.
2
[Adrenergic beta 2-agonists are to be considered more as friends than enemies].与将肾上腺素能β2激动剂视为敌人相比，它们更应被视为朋友。
Lakartidningen. 1992 Aug 5;89(32-33):2572-3.
3
[beta-adrenergic agonists and mortality and morbidity in asthma].[β-肾上腺素能激动剂与哮喘的死亡率和发病率]
Ned Tijdschr Geneeskd. 1992 Mar 7;136(10):460-5.
4
The proper role of beta 2-adrenergic agonists in the treatment of children with asthma.
Pediatrics. 1992 Oct;90(4):639-40.
5
Beta-agonists and asthma mortality. What have we learned, what questions remain?β受体激动剂与哮喘死亡率。我们学到了什么，还有哪些问题有待解决？
Drugs. 1990 Nov;40(5):653-6. doi: 10.2165/00003495-199040050-00001.
6
[Beta-adrenergic agents in asthma].[哮喘中的β-肾上腺素能药物]
Rev Alerg Mex. 1996 Jan-Feb;43(1):2-4.
7
Bronchodilator treatment in asthma. Manufacturers underestimate mortality from asthma.哮喘中的支气管扩张剂治疗。制造商低估了哮喘死亡率。
BMJ. 1993 Jun 12;306(6892):1610; author reply 1611. doi: 10.1136/bmj.306.6892.1610.
8
Beta-agonist use and death from asthma.β受体激动剂的使用与哮喘致死
JAMA. 1994 Mar 16;271(11):822-3.
9
Beta-agonist use and death from asthma.β受体激动剂的使用与哮喘致死
JAMA. 1994 Mar 16;271(11):821-2.
10
Editorial overview: asthma: what are we doing wrong?编辑综述：哮喘：我们哪里做错了？
Curr Opin Investig Drugs. 2005 May;6(5):459-60.
引用本文的文献
1
The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.ICS 药物在今日哮喘管理中的救治疗法地位：ICS 与单用 SABA 之比较。
J Allergy Clin Immunol Pract. 2024 Apr;12(4):870-879. doi: 10.1016/j.jaip.2024.01.011. Epub 2024 Jan 17.
2
New insights from GINA 2019/2020-Focus on early anti-inflammatory therapy.《2019/2020年全球哮喘防治创议》的新见解——聚焦早期抗炎治疗
Wien Klin Wochenschr. 2021 Nov;133(21-22):1215-1220. doi: 10.1007/s00508-021-01830-1. Epub 2021 Mar 26.
3
A half doubling dose change in bronchial hyperresponsiveness in a population represents an important difference.在某一人群中，支气管高反应性出现半数加倍剂量的变化代表着一个重要差异。
Transl Respir Med. 2013 Dec;1(1):4. doi: 10.1186/2213-0802-1-4. Epub 2013 Feb 27.
4
Frequent cough in unsatisfactory controlled asthma--results from the population-based West Sweden Asthma study.控制不佳的哮喘患者频繁咳嗽——基于瑞典西部人群的哮喘研究结果
Respir Res. 2014 Aug 18;15(1):79. doi: 10.1186/1465-9921-15-79.
5
Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults.对乙酰氨基酚对成人哮喘严重程度影响的随机安慰剂对照研究。
BMJ Open. 2014 Feb 12;4(2):e004324. doi: 10.1136/bmjopen-2013-004324.
6
Beta2-agonists and bronchial hyperresponsiveness.β2 激动剂与支气管高反应性
Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):143-62. doi: 10.1385/CRIAI:31:2:143.
7
Complementary and alternative medicine and asthma.
Clin Rev Allergy Immunol. 1996 Fall;14(3):321-36. doi: 10.1007/BF02802221.
8
Oxygen saturation in adults with acute asthma.成人急性哮喘患者的氧饱和度。
J Accid Emerg Med. 1996 Jan;13(1):28-30. doi: 10.1136/emj.13.1.28.
9
The effects on prescribing patterns and costs of having a special interest in asthma.对哮喘有特殊兴趣对处方模式和成本的影响。
J R Soc Med. 1995 Oct;88(10):570-5.
10
Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.哮喘中常规吸入β受体激动剂：对病情加重和肺功能的影响。
Thorax. 1993 Feb;48(2):134-8. doi: 10.1136/thx.48.2.134.
本文引用的文献
1
Prevalence and Natural History of Asthma in Schoolchildren.学龄儿童哮喘的患病率及自然史
Br Med J. 1961 Mar 11;1(5227):711-3. doi: 10.1136/bmj.1.5227.711.
2
Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine.长期吸入沙丁胺醇治疗对组胺诱发哮喘的影响。
Am Rev Respir Dis. 1980 Jun;121(6):973-8. doi: 10.1164/arrd.1980.121.6.973.
3
Screening for congenital hypothyroidism.先天性甲状腺功能减退症的筛查
Br Med J. 1980 Jul 5;281(6232):1-2.
4
Bronchial responsiveness as a function of inhaled histamine and the methods of measurement.
Bull Eur Physiopathol Respir. 1982 May-Jun;18(3):427-38.
5
Regular versus symptomatic aerosol bronchodilator treatment of asthma.哮喘的常规与症状性雾化支气管扩张剂治疗
Br J Dis Chest. 1981 Apr;75(2):215-7. doi: 10.1016/0007-0971(81)90057-7.
6
Sudden death in asthma: discussion paper.哮喘猝死：讨论文件。
J R Soc Med. 1983 Aug;76(8):662-6.
7
Recent changes in salt use and stroke mortality in England and Wales. Any help for the salt-hypertension debate?英格兰和威尔士盐摄入量及中风死亡率的近期变化。对盐与高血压之争有何帮助？
J Epidemiol Community Health. 1983 Mar;37(1):25-8. doi: 10.1136/jech.37.1.25.
8
Effects of particulate air pollution on asthmatics.颗粒物空气污染对哮喘患者的影响。
Am J Public Health. 1983 Jan;73(1):50-6. doi: 10.2105/ajph.73.1.50.
9
Mortality from asthma: a new epidemic in New Zealand.哮喘死亡率：新西兰的一种新流行病。
Br Med J (Clin Res Ed). 1982 Sep 18;285(6344):771-4. doi: 10.1136/bmj.285.6344.771.
10
Increases in deaths from asthma.哮喘致死人数增加。
Ann Allergy. 1984 Jul;53(1):20-5.
Zotero 插件